Investigation of patients with atypical or severe hyperandrogenaemia including androgen-secreting ovarian teratoma

European Journal of Endocrinology

Volumn 162, Issue 2, 2010, Pages 213-220

  Dennedy, Michael Conall ^a   Smith, Diarmuid ^b   O'Shea, Donal ^a   McKenna, T Joseph ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; DEXAMETHASONE; HYDROCORTISONE; HYDROXYPROGESTERONE; TESTOSTERONE; TETRACOSACTIDE;

ADULT; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL ADRENAL HYPERPLASIA; CUSHING SYNDROME; DIAGNOSTIC IMAGING; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERANDROGENISM; IMAGE ANALYSIS; MOON FACE; OVARIAN VEIN; OVARY POLYCYSTIC DISEASE; OVARY TERATOMA; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SYMPTOM; TESTOSTERONE BLOOD LEVEL; TRANSVAGINAL ECHOGRAPHY; VIRILIZATION;

ANDROGENS; FEMALE; HUMANS; HYPERANDROGENISM; OVARIAN NEOPLASMS; SEVERITY OF ILLNESS INDEX; TERATOMA;

EID: 75149152462     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0576     Document Type: Review

References (41)

1. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004 19 41-47.
2. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S & Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Journal of Clinical Endocrinology and Metabolism 2000 85 2434-2438.
3. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR & Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. Journal of Clinical Endocrinology and Metabolism 1998 83 3078-3082.
4. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K & Boots LR. Androgen excess in women: experience with over 1000 consecutive patients. Journal of Clinical Endocrinology and Metabolism 2004 89 453-462.
5. Carmina E & Lobo RA. Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes. Journal of Endocrinological Investigation 2007 30 111-116.
6. McKenna TJ. Screening for sinister causes of hirsutism. New England Journal of Medicine 1994 331 1015-1016.
7. Martin KA, Chang RJ, Ehrmann DA, Ibanez L, Lobo RA, Rosenfield RL, Shapiro J, Montori VM & Swiglo BA. Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 1105-1120.
8. McKenna TJ. Hirsuitism and polycystic ovary syndrome. In Clinical Endocrinology, edn 2, pp 740-760. Ed. A Grossman, London: Blackwell Scientific Publications, 1998.
9. Polson DW, Adams J,Wadsworth J & Franks S. Polycystic ovaries - a common finding in normal women. Lancet 1988 1 870-872.
10. Hague WM, Adams J, Rodda C, Brook CG, de Bruyn R, Grant DB & Jacobs HS. The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clinical Endocrinology 1990 33 501-510.
11. Goldman JM & Kapadia LJ. Virilization in a postmenopausal woman due to ovarian stromal hyperthecosis. Postgraduate Medical Journal 1991 67 304-306.
12. Barth JH, Jenkins M & Belchetz PE. Ovarian hyperthecosis, diabetes and hirsuties in post-menopausal women. Clinical Endocrinology 1997 46 123-128.
13. Merke DP & Bornstein SR. Congenital adrenal hyperplasia. Lancet 2005 365 2125-2136.
14. Speiser PW & White PC. Congenital adrenal hyperplasia. New England Journal of Medicine 2003 349 776-788.
15. Kaltsas GA, Mukherjee JJ, Jenkins PJ, Satta MA, Islam N, Monson JP, Besser GM & Grossman AB. Menstrual irregularity in women with acromegaly. Journal of Clinical Endocrinology and Metabolism 1999 84 2731-2735.
16. Cronin C, Igoe D, Duffy MJ, Cunningham SK & McKenna TJ. The overnight dexamethasone test is a worthwhile screening procedure. Clinical Endocrinology 1990 33 27-33.
17. Kaltsas GA, Isidori AM, Kola BP, Skelly RH, Chew SL, Jenkins PJ, Monson JP, Grossman AB & Besser GM. The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. Journal of Clinical Endocrinology and Metabolism 2003 88 2634-2643.
18. Montwill J, Igoe D & McKenna TJ. The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome. Steroids 1994 59 296-298.
19. Elamin MB, Murad MH, Mullan R, Erickson D, Harris K, Nadeem S, Ennis R, Erwin PJ & Montori VM. Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses. Journal of Clinical Endocrinology and Metabolism 2008 93 1553-1562.
20. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM & Montori VM. The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 1526-1540.
21. Carmina E, Rosato F, Janni A, Rizzo M & Longo RA. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. Journal of Clinical Endocrinology and Metabolism 2006 91 2-6.
22. White PC & Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine Reviews 2000 21 245-291.
23. Escobar-Morreale HF, Sanchon R & San Millan JL. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. Journal of Clinical Endocrinology and Metabolism 2008 93 527-533.
24. White PC. Steroid 11 beta-hydroxylase deficiency and related disorders. Endocrinology and Metabolism Clinics of North America 2001 30 67-79.
25. Unluhizarci K, Gokce C, Atmaca H, Bayram F & Kelestimur F. A detailed investigation of hirsutism in a Turkish population: idiopathic hyperandrogenemia as a perplexing issue. Experimental and Clinical Endocrinology & Diabetes 2004 112 504-509.
26. Pang S. Congenital adrenal hyperplasia owing to 3 beta-hydroxysteroid dehydrogenase deficiency. Endocrinology and Metabolism Clinics of North America 2001 30 81-99.
27. Korobkin M, Lombardi TJ, Aisen AM, Francis IR, Quint LE, Dunnick NR, Londy F, Shapiro B, Gross MD & Thompson NW. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 1995 197 411-418.
28. Taylor L, Ayers JW, Gross MD, Peterson EP & Menon KM. Diagnostic considerations in virilization: iodomethyl-norcholesterol scanning in the localization of androgen secreting tumors. Fertility and Sterility 1986 46 1005-1010.
29. Derksen J, Nagesser SK, Meinders AE, Haak HR & van de Velde CJ. Identification of virilizing adrenal tumors in hirsute women. New England Journal of Medicine 1994 331 968-973.
30. Buy JN, Ghossain MA, Hugol D, Hassen K, Sciot C, Truc JB, Poitout P & Vadrot D. Characterization of adnexal masses: combination of color Doppler and conventional sonography compared with spectral Doppler analysis alone and conventional sonography alone. AJR. American Journal of Roentgenology 1996 166 385-393.
31. Shaaban A & Rezvani M. Ovarian cancer: detection and radiologic staging. Clinical Obstetrics and Gynecology 2009 52 73-93.
32. Tanaka YO, Tsunoda H, Kitagawa Y, Ueno T, Yoshikawa H & Saida Y. Functioning ovarian tumors: direct and indirect findings at MR imaging. Radiographics 2004 24 S147-S166.
33. Smith D, Crotty TB, Murphy JF, Crofton ME, Franks S & McKenna TJ. A steroid cell tumor outside the ovary is a rare cause of virilization. Fertility and Sterility 2006 85 227.
34. Sorensen R, Moltz L & Schwartz U. Technical difficulties of selective venous blood sampling in the differential diagnosis of female hyperandrogenism. Cardiovascular and Interventional Radiology 1986 9 75-82.
35. Levens ED, Whitcomb BW, Csokmay JM & Nieman LK. Selective venous sampling for androgen-producing ovarian pathology. Clinical Endocrinology 2009 70 606-614.
36. Kaltsas GA, Mukherjee JJ, Kola B, Isidori AM, Hanson JA, Dacie JE, Reznek R, Monson JP & Grossman AB. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women? Clinical Endocrinology 2003 59 34-43.
37. Weiss LM, Bertagna X, Chrousos GP, Kawashima A, Kleihues P, Koch CA, Giordano TJ, Medeiros LJ, Merino MJ, Ordonez NG & Sesano H. Adrenal cortical carinoma. InWorld Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs, edn 1, pp 139-142. France: International Agency for Research on Cancer Press, 2004.
38. Loughlin T, Cunningham SK, Culliton M, Smyth PP, Meagher DJ & McKenna TJ. Altered androstenedione and estrone dynamics associated with abnormal hormonal profiles in amenorrheic subjects with weight loss or obesity. Fertility and Sterility 1985 43 720-725.
39. Wu DH, McMurtrie DG, Hirsch SD & Johnston CM. Postmenopausal hyperandrogenism caused by a benign cystic teratoma: a case report. Journal of Reproductive Medicine 2008 53 141-144.
40. McKenna TJ. Pathogenesis and treatment of polycystic ovary syndrome. New England Journal of Medicine 1988 318 558-562.
41. McKenna TJ & Cunningham SK. Adrenal abnormalities in polycystic ovary syndrome and the impact of their correction. In Current Issues in Endocrinology and Metabolism - Polycystic Ovary Syndrome, pp 183-195. Eds A Dunaif, JA Givens, P Haseltine & GR Merriam, London: Blackwell Scientific Publications, 1992.